Cholesterol lowering and ezetimibe.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. A high-performance liquid chromatography-electronic circular dichroism online method for assessing the absolute enantiomeric excess and conversion ratio of asymmetric reactions.Scientific reports · 2017
   Article
2. Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Drugs · 2015
   Review
3. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.JAMA internal medicine · 2014
   Article
4. Evaluation of Fibrous Cap Rupture of Atherosclerotic Carotid Plaque with Thin-Slice Source Images of Time-of-Flight MR Angiography.Annals of vascular diseases · 2014
   Article
5. Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.Vascular health and risk management · 2010
   Review
6. MR plaque imaging of the carotid artery.Neuroradiology · 2010
   Review
7. Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.Lipids in health and disease · 2009
   Article
8. Fact or fiction: the need for independent pharmaceutical policy research.Journal of general internal medicine · 2009
   Article
9. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2009
   Article
10. Dyslipidemia in youth with diabetes: to treat or not to treat?The Journal of pediatrics · 2008
    Review
11. Late-breaking trials at the ACC scientific sessions: insights and controversy.Current cardiology reports · 2008
    Article

Corrections and comments

• Comment on
  Simvastatin with or without ezetimibe in familial hypercholesterolemia.2008
• Comment on
  Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?2008

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as